Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
34,100
Employees34,100
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
34,100
Employees34,100

BMY Key Statistics

Market cap
97.04B
Market cap97.04B
Price-Earnings ratio
17.85
Price-Earnings ratio17.85
Dividend yield
5.56%
Dividend yield5.56%
Average volume
14.54M
Average volume14.54M
High today
$44.46
High today$44.46
Low today
$43.33
Low today$43.33
Open price
$43.61
Open price$43.61
Volume
18.63M
Volume18.63M
52 Week high
$63.33
52 Week high$63.33
52 Week low
$42.96
52 Week low$42.96

BMY News

Seeking Alpha 3d
What to expect from Bristol-Myers Squibb's Q2 earnings?

Bristol-Myers Squibb Company (NYSE:BMY) is scheduled to announce Q2 earnings results on July 31st, before markets open. Analysts expect the company’s key metri...

What to expect from Bristol-Myers Squibb's Q2 earnings?

Analyst ratings

69%

of 26 ratings
Buy
26.9%
Hold
69.2%
Sell
3.8%

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.